semaglutide and cardiovascular outcomes in obesity without diabetes SELECT Trial Semaglutide and Cardiovascular Outcomes in

Explore the benefits, risks and expectations.

PlexusDx helps identify whether you need a dose adjustment, a different medication, or personalized genetic insights to optimize your therapy

Buy Now!

Using GLP-1 drugs for weight loss is considered safe but can come with a loss of lean muscle mass

It has also been shown to help eliminate LDL "bad" cholesterol

Peptide: Retatrutide 30mg Type: Longevity Brand: Bio Stem (For research purposes only) Retatrutide is known as a triple agonist, meaning it activates:GLP-1 receptors helps control appetite + slows digestionGIP receptors improves insulin response + nutrient handlingGlucagon receptors increases energy expenditure + fat burning Retatrutide is a multi-receptor agonist currently being studied for its interaction with metabolic pathways, including GLP-1, GIP, and glucagon receptors